[发明专利]刺山柑提取物及其制备方法与应用无效
| 申请号: | 200810203382.2 | 申请日: | 2008-11-26 |
| 公开(公告)号: | CN101406497A | 公开(公告)日: | 2009-04-15 |
| 发明(设计)人: | 王长虹;王峥涛;杨涛;程雪梅;周吉燕 | 申请(专利权)人: | 上海中医药大学;上海中药标准化研究中心 |
| 主分类号: | A61K36/185 | 分类号: | A61K36/185;A61K31/7068;A61P19/02;A61P29/00;A61K131/00 |
| 代理公司: | 上海新天专利代理有限公司 | 代理人: | 王 巍 |
| 地址: | 201210上*** | 国省代码: | 上海;31 |
| 权利要求书: | 查看更多 | 说明书: | 查看更多 |
| 摘要: | 本发明公开了一种刺山柑提取物及其制备方法。该方法包括将药材粉碎后用水煎煮或用不同浓度的乙醇加热回流提取、提取液浓缩后再加入乙醇沉淀杂质、上清液或浓度高于80%的乙醇提取液减压浓缩,回收乙醇后经干燥后得提取物1。提取物1用水分散溶解后石油醚脱酯,然后用乙酸乙酯萃取,乙酸乙酯萃取部位和水溶性部位分别经减压浓缩和干燥后,分别制成提取物2和3。提取物1含有刺山柑碱A等5个新化合物在内的30个化合物。提取物2含有对羟基苯甲酸等18个化合物。提取物3含有刺山柑碱A等5个新化合物在内的18个化合物。经药效学实验显示提取物1、2和3具有镇痛、抗炎活性,可用于制备治疗风湿性关节炎、类风湿性炎或肩周炎的药物。 | ||
| 搜索关键词: | 刺山柑 提取物 及其 制备 方法 应用 | ||
【主权项】:
1、一种刺山柑提取物,其特征在于该刺山柑提取物包括提取物1、2和3;所述提取物1含有以下30种化合物:化合物1:刺山柑碱A、化合物2:刺山柑酸A、化合物3:刺山柑碱B、化合物4:刺山柑碱C、化合物5:刺山柑碱D、化合物6:对羟基苯甲酸、化合物7:原儿茶酸、化合物8:香草酸、化合物9:原儿醛、化合物10:丁香酸、化合物11:3,4-二羟基苯甲酸、化合物12:反式丁烯二酸、化合物13:乙二酸、化合物14:5-羟甲基糠醛、化合物15:5-羟甲基糠酸、化合物16:2-糠酸、化合物17:二氢-4羟基-5-羟甲基-2(3H)呋喃酮、化合物18:7-hydroxy-2-oxoindolin-3-ylacetic acid、化合物19:尿嘧啶、化合物20:L-内消旋肌醇、化合物21:尿苷、化合物22:山萘酚芸香苷、化合物23:β-胡萝卜苷-6′-硬脂酸酯、化合物24:corchoionoside C、化合物25:spionoside B、化合物26:白花菜苷、化合物27:β-谷甾醇、化合物28:β-胡萝卜苷、化合物29:芦丁、化合物30:吲哚-3-甲醛;它们的结构式如下:![]()
![]()
上述30种化合物的特征波谱数据:编 名称 波谱数据号1 刺山柑碱A 1H-NMR(DMSO-d6,500MHz)δ(ppm):11.34bar(COOH), 9.34(1H,s,CHO),7.13(1H,d,J=3.8Hz,H-8),6.29(1H, d,J=3.9Hz,H-9),5.64(1H,m,H-5),5.40m(1H,s, NH),3.08(1H,dd,J=9.2Hz,17.0Hz,H-4a),2.63(1H, dd,J=6.6Hz,17.0Hz,H-4b);13C-NMR(CD3OD,125MHz) δ(ppm):179.0(C-11),175.2(C-12),175.1(C-3),125.8(C-8), 144.9(C-10),131.3(C-7),109.7(C-9),54.8(C-1),54.7(C-5), 37.3(C-4);2 刺山柑酸 1H-NMR(DMSO,500MHz)δ(ppm):7.93(1H,s,H-2), 2.31(3H,s,CH3);13C-NMR(CD3OD,125MHz)δ(ppm): 170.6(COOH),152.2(C-4),146.1(C-3),143.2(C-5), 140.7(C-2),14.8(CH3);3 刺山柑碱B 1H-NMR(DMSO,500MHz)δ(ppm):9.54(1H,s,CHO), 6.98(1H,d,J=4.01Hz),6.21(1H,d,J=3.78Hz),5.84(1H, q,J=7.24Hz),5.48(1H,d,J=14.13Hz),5.39(1H,d, J=14.93Hz),1.72(3H,d,J=7.27Hz CH3);13C-NMR (CD3OD,125MHz)δ(ppm):179.7(C-11),168.1(C-3), 130.8(C-6),120.3(C-9),124.0(C-7),106.5(C-6),63.3(C-1), 53.8(C-4),19.1(C-10);4 刺山柑碱C 1H-NMR(DMSO,500MHz)δ(ppm):9.46(1H,s,CHO), 6.93(1H,d,J=3.69Hz,H-3),6.03(1H,d,J=3.52Hz, H-4),4.96(1H,d,J=15.35Hz,H-7a),4.76(1H,d,J=15.29 Hz,H-7b),4.66(1H,d,J=14.01Hz,H-6a),4.34(1H,d, J=13.58Hz,H-6b),4.34(1H,m,H-5′),4.25(1H,m,H-4′), 3.77(1H,dd,J=2.49,12.29Hz,H-3′a),3.69(1H,dd,J =3.64.49,11.87Hz,H-3′b),2.27(1H,m,H-6′);13C-NMR (CD3OD,125MHz)δ(ppm):178.9(C-8),134.6(C-5), 131.2(C-2),124.2(C-4),105.0(C-3),104.1(C-1′),89.7(C-1′), 72.9(C-5′),62.9(C-3′),58.0(C-7),50.3(C-6),44.9(C-6′);5 刺山柑碱D 1H-NMR(DMSO,500MHz)δ(ppm):9.45(1H,s,CHO), 6.92(1H,d,J=3.80Hz,H-7′),6.01(1H,d,J=3.46Hz, H-8′),4.82(1H,d,J=15.18Hz,H-1′a),4.74(1H,d,J =15.67Hz,H-1′b),4.70(2H,d,J=14.37Hz,H-4′a),4.02 (1H,d,J=13.82Hz,H-4′b),4.17(1H,m,H-4),3.88(1H, s,H-5),3.89(1H,d,J=12.07Hz,H-6a),3.81(1H,d,J=12.07 Hz,H-6b),2.04(1H,dd,J=5.32,12.82Hz,H-3a),1.91 (1H,t,J=12.43Hz,H-3b);13C-NMR(CD3OD,125MHz) δ(ppm):178.8(C-10′),134.1(C-9′),131.2(C-6′),124.0(C-7′), 104.8(C-8′),95.4(C-2),67.4(C-5),65.1(C-4),64.5(C-6), 57.8(C-1′),52.2(C-4′),35.8(C-3);6 对羟基苯甲酸 1H-NMR(CD3OD,500MHz)δ(ppm):7.78(2H,d,J=8.8 Hz,H-3,5),6.72(2H,d,J=8.8Hz,H-2,6),为邻位酚 羟基氢信号;13C-NMR(CD3OD,125MHz)δ(ppm):170.4 (C-7),163.6(C-4),133.3(C-2,C-6),123.0(C-1),116.3(C-3, C-5);7 原儿茶酸 1H-NMR(CD3OD,500MHz)δ(ppm):7.31(1H,d,J=1.7 Hz,H-2),7.2(1H,dd,J=8.1,1.7Hz,H-6),6.9(1H,d, J=8.1Hz,H-5);13C-NMR(CD3OD,125MHz)δ(ppm): 170.7(COOH),151.8(C-4),46.3(C-3),124.2(C-6), 123.5(C-1),118.1(C-2),116.1(C-5);8 香草酸 1H-NMR(CD3COCD3,500MHz)δ(ppm):12.44(1H,br.s, COOH),9.81(1H,br.s,OH),7.46(1H,dd,J=8.2,1.7 Hz,H-6),7.43(1H,d,J=1.7Hz,H-2),6.77(1H,d,J=8.2 Hz,H-5),3.79(3H,s,OCH3);13C-NMR(CD3COCD3, 125MHz)δ(ppm):167.5(C-1),152.1(C-4),148.1(C-5), 124.9(C-7),122.9(C-2),115.5(C-3),113.5(C-6),56.4 (OCH3);9 原儿茶醛 1H-NMR(CD3COCD3,500M Hz)δ(ppm):9.67(s,1H), 8.64(2H,br.s,OH),7.24(1H,d,J=1.84Hz,H-2),7.22 (1H,dd,J=8.03,1.86Hz,H-6),6.87(1H,d,J=8.01 Hz,H-5);10 丁香酸 1H-NMR(500MHz,CD3OD)δ(ppm):7.20(2H,s,H-2,), 3.76(6H,s,OCH3);13C-NMR(CD3OD,125MHz)δ(ppm): 167.5(COOH),148.4(C-3,5),141.6(C-4),121.5(C-1), 108.2(C-2,6),56.7(OCH3);11 3,4-二羟基苯甲酸 1H-NMR(MeOD,500MHz)δ(ppm):7.37(1H,d,J=2.0 乙酯 HzH-2),7.31(1H,dd,J=2.0,8.3Hz,H-6),6.76(1H,d, J=8.3Hz,H-5),4.13(2H,q,OCH2),1.19(3H,t,-CH3); 13C-NMR(CD3OD,125MHz)δ(ppm):166.6(C=O),150.7 (C-4),145.6(C-3),123.3(C-1,6),122.9(C-2,1),117.2 (C-5),115.7(C-2),60.8(OCH2),14.6(CH3);12 富马酸 1H-NMR(CD3OD,500MHz)δ(ppm):6.81(1H,d,J=15.8 Hz,H-2),6.48(1H,d,J=15.8Hz,H-3);13C-NMR(CD3OD, 125MHz)δ(ppm):134.8(C-2,C-3),166.1(C-1,C-4);13 丁二酸 1H-NMR(CD3OD,500MHz)δ(ppm):2.5(4H,d,J=15.8Hz, H-2,3);13C-NMR(CD3OD,125MHz)δ(ppm):176.5(C-1, C-4),30.1(C-2,C-3);14 5-羟甲基糠醛 1H-NMR(MeOD,400MHz)δ(ppm):11.16(1H,s,COOH), 7.78(1H,d,J=0.82Hz,H-3),7.22(1H,dd,J=3.32,0.36 Hz,H-5),6.62(1H,dd,J=3.33,1.73Hz,H-4);13C-NMR (MeOD,125MHz)δ(ppm):159.4(C-1′),147.6(C-5),145.9 (C-2),118.6(C-3),112.7(C-4);15 5-羟甲基糠酸 1H-NMR(CD3OD,500M Hz)δ(ppm):7.06(1H,d,J=3.42 Hz,H-3),6.36(1H,d,J=3.43Hz,H-4),4.47(3H,s,H2); 13C-NMR(CD3OD,125MHz)δ(ppm):162.08(C-2′),160.99 (C-2),45.99(C-5),120.28(C-3),110.51(C-4),57.8(C-5′);16 2-糠酸 1H-NMR(MeOD,400MHz)δ:11.16(1H,s,COOH),7.78(1H, d,J=0.82Hz,H-5),7.22(1H,dd,J=3.32,0.36Hz,H-3), 6.62(1H,t,J=3.33,1.73Hz,H-4);13C-NMR(MeOD, 125MHz)δ:159.41(s,C-1′),147.61(s,C-5),145.96(s,C-2), 118.62(s,C-4),112.71(s,C-3);17 二氢-4羟基-5-羟 1H-NMR(MeOD,500MHz)δ:4.42(1H,m,5-H);4.36(1H, 甲基-2(3H)呋喃酮 t,J=2.2Hz,J=3.5Hz,4-H);3.76(1H,dd,J=12.4Hz,J=3.3Hz 6-H);3.68(1H,dd,J=12.5Hz,J=3.6Hz,6-H);2.91(1H, dd,J=18Hz,J=6.8Hz,3-H);2.37(1H,dd,J=17.8Hz, J=2.6Hz,3-H);13C-NMR(MeOD,125MHz)δ:178.9(C-2), 90.5(C-5),69.9(C-4),62.8(C-6),39.4(C-3);18 7-hydroxy-2-oxoin 1H-NMR(MeOD,500MHz)δ:6.76(1H,t,J=7.67,H-5); dolin-3-ylacetic 6.72(1H,dd,J=1.1,7.52Hz,H-4);6.66(1H,dd,J=7.69, acid 1.5Hz,H-6);3.81(1H,dd,J=3.45Hz,6.41Hz,H-3); 2.75(1H,dd,J=16.44,J=3.46Hz,H-11);2.66(1H,dd, J=16.44,J=6.57Hz,H-11);13C-NMR(MeOD,125MHz)δ: 175.9(C-11),172.0(C-2),145.8(C-7),126.8(C-8),124.6(C-5), 123.5(C-9),121.0(C-4),115.8(C-6),44.0(C-3),34.4(C-10);19 尿嘧啶 1H-NMR(DMSO d6,500MHz)δ:13.11(1H,s),12.43(1H, s),7.59(1H,d,J=7.56Hz),5.88(1H,d,J=7.57Hz)。 13C-NMR(DMSO-d6,125MHz)δ:165.9(C-4),153.3(C-2), 101.4(C-5),142.2(C-6)。1H-NMR上的质子信号δH13.11(1H, s),12.43(1H,s)为活泼质子的信号,δH 7.59(1H,d, J=7.5H7),5.40(1H,d,J=7.5Hz)为烯质子信号。13C-NMR 谱显示4个碳信号:165.9,153.3,142.2,101.4分别归属 为不饱和酰胺、脲基和双键的碳信号;20 内消旋肌醇 13C-NMR(DMSO,400MHz)δC:74.3,72.4,72.2,71.1, 都是连氧碳,δC:72.4,71.1两个碳信号峰较高,说明它们 分别为两个碳信号,化合物应为六元环醇。 1H-NMR(DMSOO,400MHz):δ4.52(1H,d,J=3.72Hz) δ4.46(1H,d,J=4.19Hz),δ4.44(2H,d,J=3.07Hz),δ4.32(2H, d,J=5.43Hz),δ3.70(1H,d,J=2.68Hz),δ3.37(1H,dd, J=2.68.9.34Hz),δ3.11(2H,m),2.90(1H,td,J=9.1,4.07 Hz)从它们的偶合常数看,有一个氢处在e键,其它五个氢 都处于a键;21 尿苷 1H-NMR(DMSO d6,400MHz)δ:7.98(1H,d,J=8.1Hz, H-6),5.89(1H,d,J=4.6Hz,H-1′),为糖端基氢信号,因 偶合常数为4.6,表明为α构型,5.69(1H,d,J=8.1,H=8.1Hz, H-5),3.7~4.2,均为糖上的氢信号。13C-NMR(DMSO-d6, 400MHz)δ:166.5(C-4),152.8(C-2),143.0(C-6),91.0(C-5), 为尿嘧啶的碳信号,102.9为糖端基碳信号,另外的δ86.6, 76.0,71.6,62.6均为糖的碳信号,为五碳糖;22 山萘酚3-O-芸香苷 1H-NMR(DMSO-d,500MHz)δ:12.56(5OH),10.80(1H, br s,OH),10.09(1H,br s,OH),7.98(2H,d,J=8.6Hz, IH-2′,6′),6.87(2H,d,J=8.6Hz,H-3′,5′),6.41(1H,s, H-8),6.20(1H,s,H-6),5.31(1H,d,J=7.3Hz,H-1″, ofglucose),4.38(1H,brs,H-rhamnose),0.99(3H,d,J=6.1Hz, rha-CH3);13C-NMR(DMSO-d,125MHz)δ:177.3(C-4), 164.1(C-7),161.2(C-5),159.8(C-4′),156.8(C-9),156.4(C-2), 133.1(C-3),130.8(C-2′,6′),120.9(C-1′),115.0(C-3′,5′), 103.9(C-10),101.3(C-1″),100.7(C-1″′),98.7(C-6),93.7(C-8), 76.3(C-3″),75.7(C-5″),74.1(C-2″),71.8(C-4″′),70.6(C-3″′), 70.3(C-4″),69.9(C-2″′),68.2(C-5″′),66.8(C-6″),17.7(C-6″′);23 β-胡萝卜苷-6′-硬 1H-NMR(CDCl3,500MHz)δ:0.65(3H,s,C18-H),0.80-0.98 脂酸酯 (m,CH3),1.25(bra,CH2),1.47-2.00(CH2和CH),2.34(2H, t,J=7.5Hz,CH2COO),3.36(1H,m,C3-H),3.51-4.37(m, 糖上的氢),5.34(1H,m,C6-H)。13C-NMR(CDCl3,125MHz) δ:174.2,140.4,122.1,101.3,79.8,76.2,73.8,73.4, 70.5,63.6,56.8,56.2,50.2,45.9,42.4,39.8,38.9,37.3, 36.7,36.2,34.3,33.9,31.9,31.9,29.7-29.8,29.5,29.34, 29.34,29.3,29.2,28.3,26.3,25.0,24.32,23.1,22.7, 21.1,19.8,19.05,18.80,14.10,11.98,11.87;24 6,9-Dihydroxy-4, 1H-NMR(MeOD-d6,500MHz)δ:5.78(1H,s,H-5),5.70(2H, 7-megastigmadien- m,H-6,7),4.22(1H,dq,J=6.4,4.4Hz,H-9),2.41(1H, 3-onel d,J=16.8Hz,H-a),2.06(1H,d,J=16.9Hz,H-2β),1.82 (1H,d,J=1.2Hz,H-13),1.14(3H,d,J=6.5Hz,H-10), 0.94(3H,s,H-11),0.91(3H,s,H-12)。13C-NMRδ:201.5(C-3), 167.7(C-5),137.3(C-7),130.4(C-7),130.3(C-8),127.4(C-4), 80.3(C-6),69.0(C-9),51.1(C-2),42.7(C-1),24.8(C-12), 24.1(C-11),23.8(C-4),19.8(C-13);25 spionoside B 1H-NMR(DMSO-d6,500MHz)δ:6.26(1H,d,J=15.26Hz, H-7),5.94(1H,dd,J=15.25,6.11Hz,H-8),4.75(OH), 4.48(1H,dq,J=6.27,6.36Hz,H-9),4.14(1H,d,J=7.64 Hz,H-1′),3.75(2H,dd,J=7.32,2.49Hz,H-11a),3.49(1H, d,J=7.39Hz,H-11b),3.63(1H,m,H-6′a),3.38(1H,m, H-6′b),2.9~3.1(4H,m,H-2′,3′,4′,5′),2.27(d,J=17.47 Hz,H-4a),2.71(d,J=17.2Hz,H-4b),2.67(dd,J=16.78, 1.54Hz,H-2a),2.22(d,J=17.59Hz,H-2b),1.22(d,J=6.49 Hz,H-10),1.07(3H,s,H-13),0.85(3H,s,H-12)。 13C-NMR(DMSO,125MHz)δ:208.1(C-3),134.9(C-8), 127.6(C-7),99.8(C-1′),85.6(C-5),80.8(C-6),77.1(C-5′), 76.9(C-3′),76.5(C-11),73.4(C-2′),71.7(C-9),70.2(C-4′), 61.1(C-6′),52.9(C-4),47.7(C-1),51.8(C-2),22.2(C-10), 15.2(C-12),18.9(C-13);26 白花菜苷 1H-NMR(DMSO d6,500MHz)δ:5.47(1H,d,J=5.86Hz, H-8),5.11(1H,d,J=4.77Hz,H-8),5.02(1H,d,J=5.25 Hz,H-8),4.75(1H,d,J=9.79Hz,H-8),4.72(1H,t, J=5.56Hz,H-8),3.68(1H,dd,J=11.16,5.29Hz,H-8), 3.19(1H,m,H-8),3.17(1H,d,J=4.98Hz,H-8),3.063.17(2H, m,H-8),2.23(3H,s,H)。13C-NMR(DMSO,125MHz)δ: 154.2(C-1),82.0(C-1′),81.1(C-5′),78.1(C-2′),72.8(C-3′), 70.0(C-4′),61.1(C-6′),18.2(C-2);27 β-谷甾醇 略28 β-胡萝卜苷 略29 芦丁 略30 1H-indole-3-carbal- 1H-NMR(DMSO-d6,500MHz)δ:7.09~7.15(2H,overlap, dehyde 5,6-H),7.41(1H,d,J=7.7Hz,7-H),8.05(1H,d,J=2.9 Hz-H),8.09(1H,d,J=7.3Hz,4-H),9.94(1H,s,10-H), 11.02(1H,bar,N-H);13C-NMR(DMSO-d6,125MHz)8: 111.6(C-7),118.7(C-3),120.8(C-9),121.6(C-4),123.1(C-5), 124.1(C-6),136.6(C-2),136.9(C-8),183.9(C-10)。
下载完整专利技术内容需要扣除积分,VIP会员可以免费下载。
该专利技术资料仅供研究查看技术是否侵权等信息,商用须获得专利权人授权。该专利全部权利属于上海中医药大学;上海中药标准化研究中心,未经上海中医药大学;上海中药标准化研究中心许可,擅自商用是侵权行为。如果您想购买此专利、获得商业授权和技术合作,请联系【客服】
本文链接:http://www.vipzhuanli.com/patent/200810203382.2/,转载请声明来源钻瓜专利网。





